Final Results from SAUL, a Single-arm International Study of Atezolizumab in Unselected Patients with Pretreated Locally Advanced/Metastatic Urinary Tract Carcinoma.

MLA

Sternberg, Cora N., et al. “Final Results from SAUL, a Single-Arm International Study of Atezolizumab in Unselected Patients with Pretreated Locally Advanced/Metastatic Urinary Tract Carcinoma.” European Urology Focus, June 2024. EBSCOhost, https://doi.org/10.1016/j.euf.2024.05.007.

APA

Sternberg, C. N., Loriot, Y., Choy, E., Castellano, D., Lopez-Rios, F., Banna, G. L., Zengerling, F., De Giorgi, U., Gedye, C., Masini, C., Bamias, A., Garcia Del Muro, X., Duran, I., Powles, T., Retz, M., Gamulin, M., Geczi, L., Huddart, R. A., Calabrò, F., … Merseburger, A. S. (2024). Final Results from SAUL, a Single-arm International Study of Atezolizumab in Unselected Patients with Pretreated Locally Advanced/Metastatic Urinary Tract Carcinoma. European Urology Focus. https://doi.org/10.1016/j.euf.2024.05.007

Chicago

Sternberg, Cora N, Yohann Loriot, Ernest Choy, Daniel Castellano, Fernando Lopez-Rios, Giuseppe Luigi Banna, Friedemann Zengerling, et al. 2024. “Final Results from SAUL, a Single-Arm International Study of Atezolizumab in Unselected Patients with Pretreated Locally Advanced/Metastatic Urinary Tract Carcinoma.” European Urology Focus, June. doi:10.1016/j.euf.2024.05.007.